So the long-term data suggests that if you have a partial response or better, that you do well. The data show that if you do not progress by a certain time, and we’re seeing it’s around three years, that you really have a 95% or more chance of never progressing. So it’s a good timeline to be able to tell patients that this is what we’re seeing, a flattening of the survival curve, a plateau, and this plateau remains with this combination similar to other checkpoint combinations...
So the long-term data suggests that if you have a partial response or better, that you do well. The data show that if you do not progress by a certain time, and we’re seeing it’s around three years, that you really have a 95% or more chance of never progressing. So it’s a good timeline to be able to tell patients that this is what we’re seeing, a flattening of the survival curve, a plateau, and this plateau remains with this combination similar to other checkpoint combinations.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.